Annual SG&A
$10.79 M
+$1.25 M+13.08%
31 December 2023
Summary:
Gain Therapeutics annual selling, general & administrative expenses is currently $10.79 million, with the most recent change of +$1.25 million (+13.08%) on 31 December 2023. During the last 3 years, it has risen by +$3.96 million (+58.02%). GANX annual SG&A is now at all-time high.GANX Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$1.84 M
-$1.91 M-50.95%
30 September 2024
Summary:
Gain Therapeutics quarterly selling, general & administrative expenses is currently $1.84 million, with the most recent change of -$1.91 million (-50.95%) on 30 September 2024. Over the past year, it has dropped by -$196.00 thousand (-9.64%). GANX quarterly SG&A is now -50.95% below its all-time high of $3.75 million, reached on 30 June 2024.GANX Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$275.95 M
-$21.37 M-8.39%
30 September 2024
Summary:
Gain Therapeutics TTM selling, general & administrative expenses is currently -$275.95 million, with the most recent change of -$21.37 million (-8.39%) on 30 September 2024. Over the past year, it has dropped by -$286.74 million (-2658.00%). GANX TTM SG&A is now -3822.58% below its all-time high of $11.31 million, reached on 30 June 2023.GANX TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GANX Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -9.6% | -2658.0% |
| 3 y3 years | +58.0% | +3.2% | -4142.1% |
| 5 y5 years | +1843.0% | - | - |
GANX Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +58.0% | -51.0% | +3.4% | -351.2% | at low |
| 5 y | 5 years | at high | +1843.0% | -51.0% | +1737.2% | -3822.6% | at low |
| alltime | all time | at high | +4759.3% | -51.0% | +1737.2% | -3822.6% | at low |
Gain Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.84 M(-50.9%) | $9.49 M(-6.7%) |
| June 2024 | - | $3.75 M(+100.2%) | $10.17 M(+0.0%) |
| Mar 2024 | - | $1.87 M(-8.0%) | $10.16 M(-5.8%) |
| Dec 2023 | $10.79 M(+13.1%) | $2.03 M(-19.2%) | $10.79 M(-2.3%) |
| Sept 2023 | - | $2.52 M(-32.7%) | $11.04 M(-2.4%) |
| June 2023 | - | $3.74 M(+50.1%) | $11.31 M(+10.3%) |
| Mar 2023 | - | $2.49 M(+9.0%) | $10.26 M(+7.5%) |
| Dec 2022 | $9.54 M(+39.7%) | $2.29 M(-17.9%) | $9.54 M(+5.6%) |
| Sept 2022 | - | $2.79 M(+3.6%) | $9.03 M(+7.1%) |
| June 2022 | - | $2.69 M(+51.3%) | $8.43 M(+11.6%) |
| Mar 2022 | - | $1.78 M | $7.55 M |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $6.83 M(+446.5%) | - | - |
| Dec 2021 | - | $1.78 M(-18.6%) | $6.83 M(+19.8%) |
| Sept 2021 | - | $2.19 M(+20.8%) | $5.70 M(+45.8%) |
| June 2021 | - | $1.81 M(+72.3%) | $3.91 M(+77.8%) |
| Mar 2021 | - | $1.05 M(+61.8%) | $2.20 M(+76.0%) |
| Dec 2020 | $1.25 M(+125.0%) | - | - |
| Dec 2020 | - | $649.20 K(+63.0%) | $1.25 M(+108.2%) |
| Sept 2020 | - | $398.30 K(+298.3%) | $600.00 K(+197.5%) |
| June 2020 | - | $100.00 K(-1.7%) | $201.70 K(+98.3%) |
| Mar 2020 | - | $101.70 K | $101.70 K |
| Dec 2019 | $555.20 K(+150.1%) | - | - |
| Dec 2018 | $222.00 K | - | - |
FAQ
- What is Gain Therapeutics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Gain Therapeutics?
- What is Gain Therapeutics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Gain Therapeutics?
- What is Gain Therapeutics quarterly SG&A year-on-year change?
- What is Gain Therapeutics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Gain Therapeutics?
- What is Gain Therapeutics TTM SG&A year-on-year change?
What is Gain Therapeutics annual selling, general & administrative expenses?
The current annual SG&A of GANX is $10.79 M
What is the all time high annual SG&A for Gain Therapeutics?
Gain Therapeutics all-time high annual selling, general & administrative expenses is $10.79 M
What is Gain Therapeutics quarterly selling, general & administrative expenses?
The current quarterly SG&A of GANX is $1.84 M
What is the all time high quarterly SG&A for Gain Therapeutics?
Gain Therapeutics all-time high quarterly selling, general & administrative expenses is $3.75 M
What is Gain Therapeutics quarterly SG&A year-on-year change?
Over the past year, GANX quarterly selling, general & administrative expenses has changed by -$196.00 K (-9.64%)
What is Gain Therapeutics TTM selling, general & administrative expenses?
The current TTM SG&A of GANX is -$275.95 M
What is the all time high TTM SG&A for Gain Therapeutics?
Gain Therapeutics all-time high TTM selling, general & administrative expenses is $11.31 M
What is Gain Therapeutics TTM SG&A year-on-year change?
Over the past year, GANX TTM selling, general & administrative expenses has changed by -$286.74 M (-2658.00%)